Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |